Annual Total Assets
$472.84 M
-$221.98 M-31.95%
December 31, 2022
Summary
- As of March 7, 2025, SRNE annual total assets is $472.84 million, with the most recent change of -$221.98 million (-31.95%) on December 31, 2022.
- During the last 3 years, SRNE annual total assets has fallen by -$84.79 million (-15.21%).
- SRNE annual total assets is now -31.95% below its all-time high of $694.82 million, reached on December 31, 2021.
Performance
SRNE Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$456.69 M
-$3.37 M-0.73%
June 30, 2023
Summary
- As of March 7, 2025, SRNE quarterly total assets is $456.69 million, with the most recent change of -$3.37 million (-0.73%) on June 30, 2023.
- Over the past year, SRNE quarterly total assets has dropped by -$3.37 million (-0.73%).
- SRNE quarterly total assets is now -46.63% below its all-time high of $855.64 million, reached on March 31, 2022.
Performance
SRNE Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
SRNE Total Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -31.9% | -0.7% |
3 y3 years | -15.2% | -0.7% |
5 y5 years | +9.6% | -0.7% |
SRNE Total Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -31.9% | at low | -46.6% | at low |
5 y | 5-year | -31.9% | at low | -46.6% | at low |
alltime | all time | -31.9% | -100.0% | -46.6% | -100.0% |
Sorrento Therapeutics Total Assets History
Date | Annual | Quarterly |
---|---|---|
Jun 2023 | - | $456.69 M(-0.7%) |
Mar 2023 | - | $460.06 M(-2.7%) |
Dec 2022 | $472.84 M(-31.9%) | $472.84 M(-23.2%) |
Sep 2022 | - | $615.61 M(-2.6%) |
Jun 2022 | - | $632.13 M(-26.1%) |
Mar 2022 | - | $855.64 M(+23.1%) |
Dec 2021 | $694.82 M(+29.7%) | $694.82 M(-7.7%) |
Sep 2021 | - | $752.79 M(-3.4%) |
Jun 2021 | - | $778.92 M(+26.9%) |
Mar 2021 | - | $613.62 M(+14.5%) |
Dec 2020 | $535.82 M(-3.9%) | $535.82 M(-11.0%) |
Sep 2020 | - | $602.09 M(+12.9%) |
Jun 2020 | - | $533.07 M(-0.6%) |
Mar 2020 | - | $536.55 M(-3.8%) |
Dec 2019 | $557.63 M(-10.6%) | $557.63 M(-0.6%) |
Sep 2019 | - | $560.88 M(-4.5%) |
Jun 2019 | - | $587.04 M(-3.7%) |
Mar 2019 | - | $609.47 M(-2.3%) |
Dec 2018 | $624.09 M(+44.6%) | $624.09 M(+6.1%) |
Sep 2018 | - | $587.96 M(+29.9%) |
Jun 2018 | - | $452.52 M(+3.6%) |
Mar 2018 | - | $436.88 M(+1.2%) |
Dec 2017 | $431.61 M(+7.5%) | $431.61 M(-11.0%) |
Sep 2017 | - | $484.78 M(+26.0%) |
Jun 2017 | - | $384.77 M(+11.5%) |
Mar 2017 | - | $345.23 M(-14.0%) |
Dec 2016 | $401.59 M(+16.9%) | $401.59 M(+43.9%) |
Sep 2016 | - | $279.06 M(-20.6%) |
Jun 2016 | - | $351.40 M(+28.4%) |
Mar 2016 | - | $273.78 M(-20.3%) |
Dec 2015 | $343.52 M(+142.7%) | $343.52 M(+5.6%) |
Sep 2015 | - | $325.30 M(+144.9%) |
Jun 2015 | - | $132.82 M(+1.2%) |
Mar 2015 | - | $131.26 M(-7.3%) |
Dec 2014 | $141.54 M(+52.9%) | $141.54 M(+35.9%) |
Sep 2014 | - | $104.13 M(-5.6%) |
Jun 2014 | - | $110.32 M(+21.7%) |
Mar 2014 | - | $90.61 M(-2.1%) |
Dec 2013 | $92.58 M | $92.58 M(+143.7%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2013 | - | $37.98 M(+387.7%) |
Jun 2013 | - | $7.79 M(-36.1%) |
Mar 2013 | - | $12.20 M(+79.9%) |
Dec 2012 | $6.78 M(+48.4%) | $6.78 M(-14.1%) |
Sep 2012 | - | $7.89 M(-11.5%) |
Jun 2012 | - | $8.92 M(+139.4%) |
Mar 2012 | - | $3.72 M(-18.5%) |
Dec 2011 | $4.57 M(-19.7%) | $4.57 M(+38.0%) |
Sep 2011 | - | $3.31 M(-15.0%) |
Jun 2011 | - | $3.90 M(-30.3%) |
Mar 2011 | - | $5.59 M(-1.7%) |
Dec 2010 | $5.69 M(+60.0%) | $5.69 M(+162.2%) |
Sep 2010 | - | $2.17 M(-8.5%) |
Jun 2010 | - | $2.37 M(-16.4%) |
Mar 2010 | - | $2.84 M(-20.1%) |
Dec 2009 | $3.55 M(>+9900.0%) | $3.55 M(-12.4%) |
Sep 2009 | - | $4.06 M(+1287.9%) |
Jun 2009 | - | $292.20 K(-21.4%) |
Mar 2009 | - | $371.80 K(>+9900.0%) |
Dec 2008 | $0.00(-100.0%) | $0.00(-100.0%) |
Sep 2008 | - | $437.50 K(>+9900.0%) |
Jun 2008 | - | $0.00(-100.0%) |
Mar 2008 | - | $17.10 K(-21.9%) |
Dec 2007 | $21.90 K(>+9900.0%) | $21.90 K(-27.0%) |
Sep 2007 | - | $30.00 K(-43.6%) |
Jun 2007 | - | $53.20 K(-38.1%) |
Mar 2007 | - | $85.90 K(>+9900.0%) |
Dec 2006 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2006 | - | $0.00(0.0%) |
Jun 2006 | - | $0.00(0.0%) |
Mar 2006 | - | $0.00(0.0%) |
Dec 2005 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2005 | - | $0.00(0.0%) |
Jun 2005 | - | $0.00(0.0%) |
Mar 2005 | - | $0.00(0.0%) |
Dec 2004 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2004 | - | $0.00(0.0%) |
Jun 2004 | - | $0.00(0.0%) |
Mar 2004 | - | $0.00 |
Dec 2003 | $0.00 | - |
FAQ
- What is Sorrento Therapeutics annual total assets?
- What is the all time high annual total assets for Sorrento Therapeutics?
- What is Sorrento Therapeutics annual total assets year-on-year change?
- What is Sorrento Therapeutics quarterly total assets?
- What is the all time high quarterly total assets for Sorrento Therapeutics?
- What is Sorrento Therapeutics quarterly total assets year-on-year change?
What is Sorrento Therapeutics annual total assets?
The current annual total assets of SRNE is $472.84 M
What is the all time high annual total assets for Sorrento Therapeutics?
Sorrento Therapeutics all-time high annual total assets is $694.82 M
What is Sorrento Therapeutics annual total assets year-on-year change?
Over the past year, SRNE annual total assets has changed by -$221.98 M (-31.95%)
What is Sorrento Therapeutics quarterly total assets?
The current quarterly total assets of SRNE is $456.69 M
What is the all time high quarterly total assets for Sorrento Therapeutics?
Sorrento Therapeutics all-time high quarterly total assets is $855.64 M
What is Sorrento Therapeutics quarterly total assets year-on-year change?
Over the past year, SRNE quarterly total assets has changed by -$3.37 M (-0.73%)